Find out TODAY. Fill out our form for a free legal consultation with a Yasmin Lawyer who will answer your questions and fight for you and your family!

General

General side effects have included exacerbations of systemic lupus erythematosus, porphyria, chorea, and a possible diminution in lactation when given immediately postpartum. Flu syndrome, tooth disorder, infection, accidental injury, and weight gain have been reported in postmarketing experience. Free Consultation

A number of studies have suggested that use of oral contraceptives decreases the risk of ovarian cancer. Specifically, the risk of epithelial ovarian cancers is decreased by 40%. The protection against ovarian cancer may last for 10 to 15 years after discontinuation of oral contraceptives. After long term use (12 years), the risk of ovarian cancer is decreased by as much as 80%. Free Consultation

The risk of endometrial cancer is decreased by approximately 50%. Protection may last for 15 years after discontinuation and may be greatest for nulliparous women who may be at higher risk for endometrial carcinoma than other women. Free Consultation

The incidence of hospitalization for pelvic inflammatory disease is approximately 50% lower in women taking oral contraceptives. The reason for the decrease in the frequency (or severity) of pelvic inflammatory disease in women taking oral contraceptives has not been fully elucidated. Free Consultation

Some recent studies have suggested that the decrease in frequency of functional ovarian cysts reported with some older formulations may not occur in women taking newer low dose formulations.

Cardiovascular

Cardiovascular side effects of the estrogen component of this combination drug may be significant and have included hypertension. However, significant blood pressure increases generally occur only in women receiving high-dose estrogen products (50 mcg or more of ethinyl estradiol or equivalent daily). Estrogens have also been associated with edema. Other cardiovascular side effects have included aggravation of varicose veins.

Some early investigations of women taking high dose estrogen combinations (50 mcg or more of ethinyl estradiol or equivalent daily) suggested that such women may be at increased risk of cardiovascular complications (myocardial infarction, stroke, and vascular thrombosis, including venous thromboembolism). However, more recent large investigations of women taking low dose estrogen combinations have suggested that oral contraceptive use is not associated with an increased risk of serious cardiovascular complications in healthy non smoking women up to the age of 45. (For women aged 35 to 44 who smoke or who have preexisting systemic diseases that may affect the cardiovascular system, use of oral contraceptives is not recommended.) Free Consultation

However, some investigators have suggested that even the new low dose products may result in adverse effects on lipid metabolism and should prompt careful review of a woman's cardiovascular risk factors before a decision to use oral contraceptive combinations is made.

The frequency of both subarachnoid hemorrhage and thrombotic stroke has been reported by some investigators to be higher in women taking oral contraceptive hormones. However, other investigators have suggested that the risk of these effects for women using newer low dose formulations are very small for young women without underlying cardiovascular disease or other risk factors. Free Consultation

Endocrine

Endocrine and metabolic side effects have included complex alterations in plasma lipid profiles and carbohydrate metabolism. In addition, oral contraceptive use has been reported to cause conception delay. Free Consultation

All the progestins which occur in commercially available oral contraceptive combinations have adverse effects on lipid profiles. Specifically, these progestins exert antiestrogen and androgen effects and decrease HDL (and HDL2) cholesterol levels and increase LDL cholesterol levels. However, the estrogens in oral contraceptive combinations exert opposing effects. Consequently, alterations in lipid profiles are related to the relative amount and potency of the specific estrogen and progestin in a given product. Free Consultation

A number of investigations have suggested that oral contraceptive combinations may decrease glucose tolerance. However, some recent studies with low dose preparations have suggested that decreases in glucose tolerance due to oral contraceptive combinations are generally minimal.

Despite the potentially adverse effects of oral contraceptives on lipid levels and glucose tolerance, some investigators have suggested that young diabetic women without existing vascular disease or severe lipidemias may be candidates for low dose oral contraceptive combinations provided that they receive close monitoring for adverse metabolic effects. Free Consultation

Gastrointestinal

Gastrointestinal side effects have included nausea, which occurs in approximately 10% of treated women and may be more frequent during the first cycles of therapy. Some early reports suggested an association between oral contraceptive use and gallbladder disease. Abdominal pain and gastroenteritis have been reported in postmarketing experience.

Cases of oral contraceptive-induced esophageal ulceration and geographic tongue have been reported rarely.

More recent studies have suggested that the risk of gallbladder disease is minimal.

Oncologic

Oncologic side effects related to oral contraceptive use have been studied extensively. A number of studies have examined a possible relationship between the use of oral contraceptives and the development of breast cancer. Many of the studies have reported conflicting results. A committee of the World Health Organization evaluated these studies and the risks of breast cancer and concluded that: "Numerous studies have found no overall association between oral contraceptive use and risk of breast cancer." In addition, the same committee also examined a possible relationship between oral contraceptive use and neoplasms of the uterine cervix and concluded that: "There are insufficient data to draw any firm conclusions regarding the effects of combined oral contraceptives on the risk of cervical adenocarcinoma". Free Consultation

The World Health Organization committee also noted that some studies "have found a weak association between long-term use of oral contraceptives and breast cancer diagnosed before the age of 36, and perhaps up to the age 45....It is unclear whether this observed association is attributable to bias, the development of new cases of cancer, or accelerated growth of existing cancers." Free Consultation

The World Health Organization committee further concluded that there is no increased risk of breast cancer in women over the age of 45 who have previously taken oral contraceptives. In addition, studies suggest that use of oral contraceptives does not place specific groups of women (like those with a family history of breast cancer) at higher or lower risk, and variations in the hormonal content of oral contraceptives do not influence the risk of breast cancer. Free Consultation

In general, studies evaluating the potential risk of cervical cancer in patients taking oral contraceptives have been complicated by the large number of confounding factors which make investigations into the epidemiology of this neoplasm difficult. Some studies have suggested that women taking oral contraceptives are at increased risk of dysplasia, epidermoid carcinoma, and adenocarcinoma of the cervix. However, other studies have not found such an association. Free Consultation

Hepatic

The rate of death due to hepatocellular carcinoma in the United States has not changed during the last 25 years (a time during which use of oral contraceptive hormones has increased dramatically).

A committee of the World Health Organization has reported that in developing countries where hepatitis B virus infection and hepatocellular carcinoma are common, "short term use of oral contraceptives does not appear to be associated with an increased risk. Data on the effects of long term use are scarce."

A recent Italian case-control study of women with hepatocellular carcinoma has suggested that the relative risk of hepatocellular carcinoma is 2.2 for oral contraceptive users compared to women who never used oral contraceptives.

A similar American case-control study from 1989 also reported a strong association between oral contraceptive use and hepatocellular carcinoma but concluded that: "If this observed association is causal, the actual number of cases of liver cancer in the United States attributable to oral contraceptive use is small. Therefore, these findings do not have public health importance in the United States and other Western nations."

Hepatic side effects reported rarely in association with estrogen therapy and therapy with oral contraceptive combinations have included focal nodular hyperplasia, intrahepatic cholestasis, liver cell adenomas, hepatic granulomas, hepatic hemangiomas and well-differentiated hepatocellular carcinomas.

Hematologic

Cases of venous thrombosis, pulmonary embolism (sometimes fatal), and arterial thrombosis have been reported rarely.

Previous thrombotic disease is considered a contraindication to use of oral contraceptive combinations.

Hematologic side effects including thromboembolism have been associated with the use of exogenous estrogens. However, because the dose of exogenous estrogens is low in most commercially available preparations, the risk is minimal for most women (except women who are over age 35 and smoke and women with a previous history of thrombotic diseases).

Genitourinary

Genitourinary side effects have included breakthrough bleeding and spotting, especially during the first several cycles of oral contraceptive use. Non-hormonal causes of such bleeding should be excluded. Vaginitis, dysmenorrhea, and candidiasis have been reported. Metrorrhagia, suspicious Papanicolaou smear, vaginal moniliasis, menorrhagia, urinary tract infection, breast pain, dysmenorrhea, menstrual disorder, amenorrhea, and urine abnormality have been reported in postmarketing experience.

Some women have experienced oligomenorrhea and amenorrhea following termination of oral contraceptive use.

Psychiatric

Psychiatric side effects have included mood changes, depression and precipitation of panic disorder.

Immunologic

Immunologic side effects have included rare reports of oral contraceptive-induced systemic lupus erythematosus.

Other

A case of fatal pulmonary occlusive disease has been associated with oral contraceptive therapy.

Nervous system

Nervous system side effects have included chorea, which has been reported once in association with oral contraceptives. Headache and asthenia have been reported in postmarketing experience.

Ocular

Ocular side effects have included retinal thrombosis, which has been reported rarely. In addition, the manufacturers of oral contraceptive products report that some patients have developed changes in contact lens tolerance. Postmarketing experience has included very rare reports of eye inflammation including iritis and uveitis. Optic neuritis, which may lead to partial or complete loss of vision, has been reported.

Metabolic

Metabolic side effects reported with the use of drospirenone have included increased serum potassium levels.

Musculoskeletal

Musculoskeletal side effects have included very rare postmarketing reports of osteonecrosis of the jaw. Arthralgia has been reported in postmarketing experience.

Hypersensitivity

Hypersensitivity side effects have included anaphylactic/anaphylactoid reactions, including urticaria, angioedema, and severe reactions with respiratory and circulatory symptoms.

Respiratory

Respiratory side effects have included upper respiratory infection, sinusitis, pharyngitis, sore throat, rhinitis, and bronchitis in postmarketing reports

One recent study (The Nurses' Health Study) has suggested that long term use of oral contraceptives is safe and does not adversely affect long term risk for mortality.

We believe that the manufacturers of Yaz, Yasmin and Ocella should be held accountable for any harm they are legally responsible for and people should be fairly compensated for their damages. Many women have had their life changed in a number of ways. If you have suffered from side effects of Yasmin such as a pulmonary embolism, blood clot or stroke please contact us by calling or via e-mail for a free confidential no-obligation consultation from a Yasmin lawsuit attorney. >

Many times, when an individual has suffered a severe illness or an acute medical event such as a heart attack or stroke, she may not be aware that a prescription drug such as Yasmin or YAZ is responsible for the injury. Physicians treating the injury may also be unaware of the connection. However, the Yasmin lawyers and YAZ lawyers at Bernhard Liebhard can help guide women through how to determine whether a woman's use of Yaz or Yasmin has contributed to the adverse event. Free Consultation

A Yasmin/YAZ Lawsuit May Be Appropriate After an attorney's thorough investigation of such a potential product liability case, a YAZ or Yasmin lawsuit may or may not be the appropriate step to take. In many cases, a defendant — such as Bayer Healthcare, the maker of both YAZ and Yasmin — would rather settle a case by offering an amount of money to a plaintiff (the injured party) as compensation for her losses. Free Consultation

However, our YAZ birth control lawyers are seasoned attorneys, familiar with all of the tactics and strategies used by defendants. Our Yasmin Drug Reaction attorneys provide very knowledgeable legal counsel to clients regarding the options and decisions necessary to arrive at a fair, satisfying outcome. Free Consultation

If you have more questions or would like to consult with our yasmin lawyers about a potential case or discuss your Yasmin side effects concerns by phone or in person, contact our Yasmin attorneys. Your Yasmin lawsuit options will be discussed in detail, and your legal options will be explained. Free Consultation

Yaz and Yasmin are two of the most popular oral contraceptives on the market. However, tragically, these birth control pills have proven fatal for at least 50 women, according to reports made to the FDA. Yaz and Yasmin present an increased risk of potentially fatal side effects over other birth control pills.

Causes of Yaz and Yasmin deaths

Numerous life-threatening side effects are associated with the use of Yaz and Yasmin, including:

If a woman does not receive adequate and immediate treatment for any of the above conditions, these side-effects can result in death.

Increased risk for Yaz and Yasmin fatal side effects

Yaz and Yasmin are more dangerous for some women than others. Women with the highest risk of developing a fatal Yasmin/Yaz side effect are those who:

Yaz and Yasmin wrongful death lawsuits

If you have lost a loved one or family member due to fatal side effects from Yaz or Yasmin, you should contact a Yaz/Yasmin lawsuit attorney immediately about bringing a wrongful death lawsuit.

A successful Yaz wrongful death lawsuit can result in compensation for funeral and burial expenses, medical expenses and pain and suffering.

The number of lawsuits filed over the birth control pills Yaz and Yasmin is now at nearly 1,100. This is according to an annual report released by Bayer, the manufacturer of Yasmin and Yaz.

Experts are predicting that the number will continue to rise as thousands of women in both Canada and the United States are considering bringing lawsuits after suffering injuries from taking Yasmin and Yaz.

According to Bayer’s 2009 annual report, which was released last month, among the lawsuits filed have been five Yaz and Yasmin class action lawsuits – three in the United States and two in Canada.

The lawsuits all involve similar issues, which are claims that Yaz, Yasmin and the generic version Ocella increase a woman’s risk of suffering a heart attack, stroke, deep vein thrombosis, pulmonary embolism or gallbladder disease, among other injuries. At least 50 deaths in the United States alone have been linked to the use of Yaz or Yasmin.

In their Yasmin and Yaz lawsuits, the plaintiffs are arguing that Bayer failed to perform adequate research on the safety of the birth control pills and failed to warn users of the increased health risks associated with Yaz and Yasmin.

Additionally, many of the Yaz and Yasmin lawsuits allege that Bayer was deceptive in its advertising of the birth control pills, over-emphasizing certain supposed benefits of the drugs without also fully disclosing the potential increased risks of serious side effects posed by Yaz and Yasmin.

In fact, Bayer was formally warned about the deceptive advertising by the FDA and subsequently forced to run a series of ads correcting the misleading claims made in previous commercials.

If you or someone you love has been injured as a result of taking Yaz, Yasmin or Ocella, contact a Yaz/Yasmin lawsuit attorney today for legal advice.

What Damages Can I recover in A Yasmin Lawsuit

Women across the United States are bringing Yaz and Yasmin lawsuits because they have suffered serious, adverse side-effects after taking these birth control pills.

If you have been injured by taking Yaz or Yasmin, you may be entitled to financial compensation for your injuries and related expenses.

“Damages” is the legal term for the financial compensation awarded to a plaintiff in a successful lawsuit. A woman who successfully brings a Yasmin or Yaz lawsuit will be awarded damages that represent compensation for her physical injuries, emotional suffering and financial losses.

The damages you could potentially recover if you win your Yaz/Yasmin lawsuit include:

For free legal advice about Yaz and Yasmin lawsuits, contact Fears | Nachawati today. To receive your no charge consultation with one of our Yaz/Yasmin lawsuit attorneys, simply email us or phone us toll free at 1.888.232.7313

The Importance of Hiring a Yasmin Lawyer

Yaz claims and Yasmin lawsuits continue to rise as our Yaz lawyers and a handful of other firms continue to build cases against Bayer in connection with its marketing of Yaz for uses that the FDA did not approve. Most Yaz clients our firm represent have suffered a stroke, heart attack, or deep vein thrombosis. Some clients have also suffered from gall bladder disease. Most of the suits that have been filed so far are being removed from state court and transferred to Illinois' Southern District Court, where The Honorable Judge Herndon presides over the Yaz cases. It is important for women who have suffered Yaz injuries to come forward early on and hire a Yaz lawyer or Yasmin law firm to ensure that the evidence continues to rise against Bayer and its subsidiaries through additional testimony concerning injuries. Anyone who has suffered from an injury because of Yaz usage anywhere in the nation is encouraged to contact our Yaz lawyers directly by email - mn@fnlawfirm.com - or by toll free telephone for a free consultation. 1.888.232.7313

.

Hire The Best Possible Yasmin Attorney For Your Lawsuit

People often do not know where to turn when it comes to dealing with a serious personal injury case or finding the best or top injury lawyers. Here are some factors you should consider when it comes to hiring a personal injury lawyer:

Factors important in hiring the Best Personal Injury Lawyer:

1. Has the lawyer or law firm your are considering hiring ever tried a lawsuit? If so, when was their last trial and what was the outcome?

2. Has the lawyer you are considering hiring ever been disciplined by the State Bar of Texas? (check www.texasbar.com)

3. Has the lawyer ever completed a judicial clerkship--a prestiguous honor bestowed on only approximately 2% of lawyers in the nation?

4. Does the lawyer you are considering hiring sound well-informed and knowledgeable regarding personal injury law?

5. Has the lawyer ever settled a case or tried a case and obtained a significant recovery?

6. Does your lawyer have the necessary resources to prosecute your case?

7. Can you relate to the lawyer and does your intuition tell you that the lawyer is trustworthy?

8. Where did the lawyer go to law school, and more importantly, what has the lawyer's practical experience been since law school? Remember, years of experience does not necessarily mean a more competent lawyer.

Our Yasmin Lawyers Will Help With The Cost

Yaz and Yasmin lawyers work on a contingency basis which means there are no upfront legal fees for the client. Any and all payment to the Yaz lawyer will be paid out of any settlement or verdict if the case is tried. Yaz legal help is widely available, but victims of Yaz should look for Top Yaz Lawyers who have experience battling the big pharmaceutical companies. Deep Vein Thrombosis, Stroke, Embolisms, Death, Clots and Gall bladder complications remain the major events experienced by women across the nation. Our Yaz lawyers at Fears | Nachawati Law Firm have the experience necessary to represent women hurt by the dangerous drug yaz. If you are looking for the top and best Yaz lawyers, contact Fears | Nachawati Law Firm at (888)232-7313.

&Copy; 2007 by Nationwide Personal Injury Attorney. All rights reserved. Disclaimer | Site Map